Appointment of Dr. Rosalind Wilson as CEO
Filed with ASX · · 2 pages · English
InVert Graphite Limited on 6ix
Earlier from InVert Graphite
- Appendix 4C
- Phase II clinical trial progress update
- Half Year Accounts
- Appendix 4C - December 2016 quarter
- Phase II Clinical Trial - First Patient In
Later from InVert Graphite
- Appendix 4C - quarterly
- Appendix 4E and Full Year Statutory Accounts
- Shareholder communication - clinical trial update
- Appendix 4C for the September Quarter
- 50% recruitment reached in VF00102 Clinical Trial
Follow InVert Graphite into a list and get an email when it puts out news.
Follow InVert Graphite